Drug recall · January 25, 2017
Donepezil Hydrochloride Tablets recall
Why: Subpotent Drug: out of specification results for assay test.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Donepezil Hydrochloride Tablets, 10 mg, packaged in a) 30-count bottles (NDC 0781-5275-31) and b) 1000-count bottles (NDC 0781-5275-10), Rx only, Manufactured in India by Sandoz Private Ltd for Sandoz Inc., Princeton, NJ 08540.
- Lots / codes
Lot #: a) FJ6599, Exp 05/17 and b) FJ6600, Exp 05/17
- Quantity
- a) 10,200 bottles; b) 300 bottles
- Company
- Sandoz Inc, Princeton, NJ
- Distribution
- Nationwide in the USA
- Initiated
- December 13, 2016 · Voluntary: Firm initiated
- Classified
- January 19, 2017
- Reported
- January 25, 2017
- Ended
- September 14, 2017
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Donepezil
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.